Web Desc
Microbiome in Health and Disease
joint with Inflammation-Driven Cancer: Mechanisms to Therapy
Organizer(s): Julie A. Segre, Ramnik Xavier and William Michael Dunne
Date: February 05 - 09, 2017
Location: Keystone Resort, Keystone, CO, USA
Sponsored by Intercept Pharmaceuticals, Inc., Merck & Co., Inc. and Novartis Institutes for BioMedical Research. Part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation.
For important information on the coronavirus, please click here
Summary of Meeting:
This Keystone Symposia meeting brings together experts in clinical medicine, clinical microbiology, microbial genomics, and bacterial genetics to explore how both strain variation and underlying microbial community determine health and disease. Genomic advances provide higher-level resolution to both pathogen and host genetic determinants. This meeting aims to explore how monitoring and potentially altering the microbial community may modulate and predict disease risk.
Global Health Travel Award Deadline: September 6 2016
Scholarship Deadline: October 6 2016
Discounted Abstract Deadline: October 6 2016
Abstract Deadline: November 3 2016
Discounted Registration Deadline: December 7 2016
Abstract submission is now closed. Registered attendees may bring a poster onsite. Please contact our office at +1 800-253-0685; +1 970-262-1230 or email info@keystonesymposia.org if you are interested.


Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:
Bill & Melinda Gates FoundationIntercept Pharmaceuticals, Inc.Merck & Co., Inc.Novartis Institutes for BioMedical Research
We gratefully acknowledge additional support for this conference from:
Anaerobe SystemsDiversigeneLifeResearch Diets, Inc.Seres Therapeutics
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

bioMérieux, Inc.
We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Allergy and Infectious Diseases (NIAID)
Grant No. 1R13AI129385-01
The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

Program

Sunday, February 05 | 4:00PM - 8:00PM
Arrival and Registration
Room: Longs Peak Foyer


Sunday, February 05 | 6:00PM - 8:00PM
Welcome Mixer
Room: Longs Peak Foyer
No registration fees are used to fund alcohol served at this function.

Monday, February 06 | 7:00AM - 8:00AM
Breakfast
Room: Colorado Rockies Ballroom


Monday, February 06 | 8:00AM - 9:00AM
Welcome and Keynote Address
Room: Grays/Longs Peak

Speaker 1 of 2
* Julie A. Segre, National Institutes of Health, USA

Monday, February 06 | 8:00AM - 9:00AM
Welcome and Keynote Address
Room: Grays/Longs Peak

Speaker 2 of 2
Sarkis K. Mazmanian, California Institute of Technology, USA
The Gut-Microbiome-Brain Connection in Neurological Diseases

Monday, February 06 | 9:00AM - 11:15AM
Monitoring Microbiome to Predict Disease Risk
Room: Grays/Longs Peak

Speaker 1 of 5
* William Michael Dunne, bioMérieux, Inc., USA

Monday, February 06 | 9:00AM - 11:15AM
Monitoring Microbiome to Predict Disease Risk
Room: Grays/Longs Peak

Speaker 2 of 5
Hera Vlamakis, Broad Institute, USA
IBD, Crohn’s Microbiome

Monday, February 06 | 9:00AM - 11:15AM
Monitoring Microbiome to Predict Disease Risk
Room: Grays/Longs Peak


Coffee Break

Monday, February 06 | 9:00AM - 11:15AM
Monitoring Microbiome to Predict Disease Risk
Room: Grays/Longs Peak

Speaker 4 of 5
Dan R. Littman, HHMI/New York University School of Medicine, USA
Regulation of T Cell Responses by Microbiota

Monday, February 06 | 9:00AM - 11:15AM
Monitoring Microbiome to Predict Disease Risk
Room: Grays/Longs Peak

Speaker 5 of 5
Curtis C. Harris, NCI, National Institutes of Health, USA
Microbiome-TP53 Gene Interaction in Human Lung Cancer

Monday, February 06 | 9:00AM - 11:15AM
Inflammation-Driven Cancer
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 1 of 6
* Michael Karin, University of California, San Diego, USA


Monday, February 06 | 9:00AM - 11:15AM
Inflammation-Driven Cancer
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 2 of 6
Fiona M. Powrie, University of Oxford, UK
Inflammation-Driven Cancer: Host and Microbial Pathways


Monday, February 06 | 9:00AM - 11:15AM
Inflammation-Driven Cancer
This session is from Inflammation-Driven Cancer
Room: Quandary Peak


Coffee Break


Monday, February 06 | 9:00AM - 11:15AM
Inflammation-Driven Cancer
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 4 of 6
Mathias Florian Heikenwälder, German Cancer Research Center, DKFZ, Germany
On the Role of Immune Cells in NASH and NASH to HCC Transition


Monday, February 06 | 9:00AM - 11:15AM
Inflammation-Driven Cancer
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 5 of 6
Arthur Kaser, University of Cambridge, UK
ER Stress and Colorectal Cancer


Monday, February 06 | 9:00AM - 11:15AM
Inflammation-Driven Cancer
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 6 of 6
Jeonghyun Ahn, University of Miami, USA
Short Talk: The Role of STING in Suppressing Inflammation-Driven Intestinal Tumorigenesis


Monday, February 06 | 11:15AM - 12:30PM
NIH Institutes’ Interests in Microbiome Research
Room: Grays/Longs Peak

Speaker 1 of 6
* Robert W. Karp, National Institutes of Health, USA

Monday, February 06 | 11:15AM - 12:30PM
NIH Institutes’ Interests in Microbiome Research
Room: Grays/Longs Peak

Speaker 2 of 6
Ryan Ranallo, NIAID, National Institutes of Health, USA

Monday, February 06 | 11:15AM - 12:30PM
NIH Institutes’ Interests in Microbiome Research
Room: Grays/Longs Peak

Speaker 3 of 6
Phil J. Daschner, NCI, National Institutes of Health, USA

Monday, February 06 | 11:15AM - 12:30PM
NIH Institutes’ Interests in Microbiome Research
Room: Grays/Longs Peak

Speaker 4 of 6
Elisabet Caler, NHLBI, National Institutes of Health, USA

Monday, February 06 | 11:15AM - 12:30PM
NIH Institutes’ Interests in Microbiome Research
Room: Grays/Longs Peak

Speaker 5 of 6
Ricardo R. Cibotti, NIAMS, National Institutes of Health, USA

Monday, February 06 | 11:15AM - 12:30PM
NIH Institutes’ Interests in Microbiome Research
Room: Grays/Longs Peak

Speaker 6 of 6
Francesca Macchiarini, NIA, National Institutes of Health, USA

Monday, February 06 | 11:15AM - 1:00PM
Poster Setup
Room: Colorado Rockies Ballroom


Monday, February 06 | 12:30PM - 5:00PM
On Own for Lunch


Monday, February 06 | 1:00PM - 10:00PM
Poster Viewing
Room: Colorado Rockies Ballroom


Monday, February 06 | 2:30PM - 4:30PM
Workshop 1: Microbiome in Health and Disease
Room: Grays/Longs Peak

Speaker 1 of 7
* Ami S. Bhatt, Stanford University, USA

Monday, February 06 | 2:30PM - 4:30PM
Workshop 1: Microbiome in Health and Disease
Room: Grays/Longs Peak

Speaker 2 of 7
Michael C. Abt, Sloan Kettering Institute, USA
Host Immune Response Supports Fecal Microbiota Transplant-Mediated Clearance of Clostridium Difficile Infection

Monday, February 06 | 2:30PM - 4:30PM
Workshop 1: Microbiome in Health and Disease
Room: Grays/Longs Peak

Speaker 3 of 7
Dingding An, Harvard Medical School, USA
Microbial Sphingolipids Modulate Host Epithelium Homeostasis and Disease

Monday, February 06 | 2:30PM - 4:30PM
Workshop 1: Microbiome in Health and Disease
Room: Grays/Longs Peak

Speaker 4 of 7
Naama Geva-Zatorsky, Harvard Medical School, USA
Gut Microbiota-Host Interactions and their Immune Modulations

Monday, February 06 | 2:30PM - 4:30PM
Workshop 1: Microbiome in Health and Disease
Room: Grays/Longs Peak

Speaker 5 of 7
Yun-Gi Kim, Keio University, Japan
Neonatal Acquisition of Clostridia Species Controls Colonization Resistance Against Bacterial Pathogens

Monday, February 06 | 2:30PM - 4:30PM
Workshop 1: Microbiome in Health and Disease
Room: Grays/Longs Peak

Speaker 6 of 7
Monica Viladomiu, Weill Cornell Medicine, USA
Functional Characterization of IgA-Targeted E. coli in Crohn's Disease-Associated Spondyloarthritis Links Mucosal Immunity with Systemic Inflammation

Monday, February 06 | 2:30PM - 4:30PM
Workshop 1: Microbiome in Health and Disease
Room: Grays/Longs Peak

Speaker 7 of 7
Xochitl Morgan, University of Otago, New Zealand
Gut Microbiota Acquisition in New Zealand Children in Relation to Early Life Exposures Including Probiotics: A Longitudinal Analysis

Monday, February 06 | 2:30PM - 4:30PM
Workshop 1: Inflammation-Driven Cancer
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 1 of 9
* Hua E. Yu, Beckman Research Institute, City of Hope, USA


Monday, February 06 | 2:30PM - 4:30PM
Workshop 1: Inflammation-Driven Cancer
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 2 of 9
* Mathias Florian Heikenwälder, German Cancer Research Center, DKFZ, Germany


Monday, February 06 | 2:30PM - 4:30PM
Workshop 1: Inflammation-Driven Cancer
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 3 of 9
Ryan Kolb, University of Iowa, USA
IL-1beta Promotes Obesity-driven Breast Cancer Progression through the Upregulation of ANGPTL4 in Adipocytes


Monday, February 06 | 2:30PM - 4:30PM
Workshop 1: Inflammation-Driven Cancer
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 4 of 9
Sarah McCuaig, University of Oxford, UK
Cytokine-Oncogene Synergies in Colorectal Cancer


Monday, February 06 | 2:30PM - 4:30PM
Workshop 1: Inflammation-Driven Cancer
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 5 of 9
Seyed Javad Moghaddam, University of Texas MD Anderson Cancer Center, USA
Muc5ac Plays an Essential Role in Promotion of K-ras Mutant Lung Cancer by Inflammation


Monday, February 06 | 2:30PM - 4:30PM
Workshop 1: Inflammation-Driven Cancer
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 6 of 9
Karen Pickering, Beatson Institute, UK
Guanine Nucleotide Exchange Factor Vav1 Promotes Survival in Colorectal Cancer through T-Cell Activation


Monday, February 06 | 2:30PM - 4:30PM
Workshop 1: Inflammation-Driven Cancer
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 7 of 9
Na-Young Song, Yonsei University College of Dentistry, South Korea
Determining the Signaling Pathway of Epithelial-IKKalpha-Deletion-Mediated Symbiotic Bacterial and Fungal Infection in Carcinogenesis


Monday, February 06 | 2:30PM - 4:30PM
Workshop 1: Inflammation-Driven Cancer
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 8 of 9
Chunfeng Qu, Cancer Institute/Hospital, Chinese Academy of Medical Sciences, China
Liver Inflammatory Macrophages in Response to Hepatitis B Virus (HBV) Proteins Promote Hepatocellular Carcinoma by Enhancing Angiogenesis through IL23/IL23R Interaction


Monday, February 06 | 2:30PM - 4:30PM
Workshop 1: Inflammation-Driven Cancer
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 9 of 9
Martina Seiffert, German Cancer Research Center, Germany
Tumor Exosome-Derived Y RNA Activates TLR7/8 Signaling in Monocytes and Contributes to Cancer Inflammation and Immune Escape


Monday, February 06 | 4:30PM - 5:00PM
Coffee Available
Room: Longs Peak Foyer


Monday, February 06 | 5:00PM - 7:15PM
Microbiome and Cancer (Joint)
Room: Longs/Grays Peak

Speaker 1 of 5
* Arthur Kaser, University of Cambridge, UK

Monday, February 06 | 5:00PM - 7:15PM
Microbiome and Cancer (Joint)
Room: Longs/Grays Peak

Speaker 2 of 5
Laurence Zitvogel, Institut Gustave Roussy, France
Microbe-Driven Anti-Tumor Immunity

Monday, February 06 | 5:00PM - 7:15PM
Microbiome and Cancer (Joint)
Room: Longs/Grays Peak

Speaker 3 of 5
Giorgio Trinchieri, NCI, National Institutes of Health, USA
Role of the Microbiota in Inflammation, Carcinogenesis and Cancer Therapy

Monday, February 06 | 5:00PM - 7:15PM
Microbiome and Cancer (Joint)
Room: Longs/Grays Peak

Speaker 4 of 5
Curtis Huttenhower, Harvard School of Public Health, USA
Functional Analysis of Strains in the Human Gut Metatranscriptome

Monday, February 06 | 5:00PM - 7:15PM
Microbiome and Cancer (Joint)
Room: Longs/Grays Peak

Speaker 5 of 5
Cynthia L. Sears, Johns Hopkins University School of Medicine, USA
The carcinogenic potential of bacterial biofilms

Monday, February 06 | 7:15PM - 8:15PM
Social Hour with Lite Bites
Room: Colorado Rockies Ballroom
No registration fees are used to fund alcohol served at this function.

Monday, February 06 | 7:30PM - 10:00PM
Poster Session 1
Room: Colorado Rockies Ballroom


Tuesday, February 07 | 7:00AM - 8:00AM
Breakfast
Room: Colorado Rockies Ballroom


Tuesday, February 07 | 8:00AM - 11:00AM
Complex Microbiome Analyses
Room: Grays/Longs Peak

Speaker 1 of 7
* Julie A. Segre, National Institutes of Health, USA

Tuesday, February 07 | 8:00AM - 11:00AM
Complex Microbiome Analyses
Room: Grays/Longs Peak

Speaker 2 of 7
Rob Knight, University of California, San Diego, USA
Human Microbiome and Metabolome Dynamics

Tuesday, February 07 | 8:00AM - 11:00AM
Complex Microbiome Analyses
Room: Grays/Longs Peak

Speaker 3 of 7
Gautam Dantas, Washington University School of Medicine, USA
Networks of Exchanging Antibiotic Resistance Between Commensal, Environmental, and Pathogenic Bacteria

Tuesday, February 07 | 8:00AM - 11:00AM
Complex Microbiome Analyses
Room: Grays/Longs Peak


Coffee Break

Tuesday, February 07 | 8:00AM - 11:00AM
Complex Microbiome Analyses
Room: Grays/Longs Peak

Speaker 5 of 7
Michael A. Fischbach, Stanford University, USA
Small Molecules from the Human Microbiota

Tuesday, February 07 | 8:00AM - 11:00AM
Complex Microbiome Analyses
Room: Grays/Longs Peak

Speaker 6 of 7
Katherine S. Pollard, University of California, San Francisco, USA
Decoding Cryptic Variation in the Human Microbiome

Tuesday, February 07 | 8:00AM - 11:00AM
Complex Microbiome Analyses
Room: Grays/Longs Peak

Speaker 7 of 7
Kelly Wen Li Chen, Massachusetts Institute of Technology, USA
Short Talk: Integrated Gut/Liver Microphysiological System Elucidates Cytokine/Chemokine Inter-Tissue Crosstalk under Endotoxin-Induced Stress

Tuesday, February 07 | 8:00AM - 11:15AM
Inflammation and Cancer Stem Cells
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 1 of 8
* Owen J. Sansom, Beatson Institute of Cancer Research, UK


Tuesday, February 07 | 8:00AM - 11:15AM
Inflammation and Cancer Stem Cells
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 2 of 8
Matthias Ernst, Olivia Newton-John Cancer Research Institute, Australia
Excessive HCK Kinase Activity in the Tumor Stroma Polarizes Macrophages and Promotes Solid Malignancies


Tuesday, February 07 | 8:00AM - 11:15AM
Inflammation and Cancer Stem Cells
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 3 of 8
Simon J. Leedham, University of Oxford, UK
Morphogen Signaling in Intestinal Inflammation and Carcinogenesis


Tuesday, February 07 | 8:00AM - 11:15AM
Inflammation and Cancer Stem Cells
This session is from Inflammation-Driven Cancer
Room: Quandary Peak


Coffee Break


Tuesday, February 07 | 8:00AM - 11:15AM
Inflammation and Cancer Stem Cells
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 5 of 8
Fiona M. Watt, King's College London School of Medicine, UK
Contribution of Different Epidermal Cell Populations to Inflammation-Associated Cancers


Tuesday, February 07 | 8:00AM - 11:15AM
Inflammation and Cancer Stem Cells
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 6 of 8
Judith A. Varner, University of California, San Diego, USA
Targeting Macrophage Signaling to Suppress Tumor Progression


Tuesday, February 07 | 8:00AM - 11:15AM
Inflammation and Cancer Stem Cells
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 7 of 8
Min-Kyung Choo, Takeda, USA
Short Talk: p38 MAPK Functions as a Tumor Suppressor in Skin Epithelial Cells, but as a Tumor Promoter in Myeloid Cells


Tuesday, February 07 | 8:00AM - 11:15AM
Inflammation and Cancer Stem Cells
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 8 of 8
Jelena Todoric, University of California, San Diego, USA
Short Talk: A Stress Activated p62-NRF2-MDM2 Axis Drives Pancreatic Tumorigenesis


Tuesday, February 07 | 11:00AM - 5:00PM
On Own for Lunch


Tuesday, February 07 | 11:00AM - 1:00PM
Poster Setup
Room: Colorado Rockies Ballroom


Tuesday, February 07 | 1:00PM - 10:00PM
Poster Viewing
Room: Colorado Rockies Ballroom


Tuesday, February 07 | 2:30PM - 4:30PM
Panel: The Integrative Human Microbiome Project (iHMP)
Room: Grays/Longs Peak
The Integrative Human Microbiome Project (iHMP) is the second phase of the National Institute of Health (NIH) Common Fund's Human Microbiome Project (HMP) program. The mission of the overall HMP is to generate resources to permit comprehensive characterization of the human microbiota to further our understanding of how the microbiome impacts human health and disease. In this phase of the program, the iHMP is creating integrated longitudinal datasets of biological properties from both the microbiome and host from three different cohort studies of microbiome-associated conditions using multiple 'omics' technologies. Tools, datasets and other resources from the first phase of the project are available at the HMP DACC. The three iHMP projects have recently completed primary data generation and are entering an initial analysis phase, and this session will detail the data and resources made available to the research community by: 1) the Multi-Omic Microbiome Study: Pregnancy Initiative (MOMS-PI) at Virginia Commonwealth University, 2) the Inflammatory Bowel Disease Multi'omic Data (IBDMDB) resource from the Broad Institute and a nation-wide research tam, and 3) Integrated Personal 'Omics Profiling (IPOP) from Stanford University and the Jackson Laboratory for Genomic Medicine. For more information or to get involved with the iHMP, please see http://hmp2.org.
Speaker 1 of 4
* Curtis Huttenhower, Harvard School of Public Health, USA

Tuesday, February 07 | 2:30PM - 4:30PM
Panel: The Integrative Human Microbiome Project (iHMP)
Room: Grays/Longs Peak
The Integrative Human Microbiome Project (iHMP) is the second phase of the National Institute of Health (NIH) Common Fund's Human Microbiome Project (HMP) program. The mission of the overall HMP is to generate resources to permit comprehensive characterization of the human microbiota to further our understanding of how the microbiome impacts human health and disease. In this phase of the program, the iHMP is creating integrated longitudinal datasets of biological properties from both the microbiome and host from three different cohort studies of microbiome-associated conditions using multiple 'omics' technologies. Tools, datasets and other resources from the first phase of the project are available at the HMP DACC. The three iHMP projects have recently completed primary data generation and are entering an initial analysis phase, and this session will detail the data and resources made available to the research community by: 1) the Multi-Omic Microbiome Study: Pregnancy Initiative (MOMS-PI) at Virginia Commonwealth University, 2) the Inflammatory Bowel Disease Multi'omic Data (IBDMDB) resource from the Broad Institute and a nation-wide research tam, and 3) Integrated Personal 'Omics Profiling (IPOP) from Stanford University and the Jackson Laboratory for Genomic Medicine. For more information or to get involved with the iHMP, please see http://hmp2.org.
Speaker 2 of 4
Jennifer M. Fettweis, Virginia Commonwealth University, USA

Tuesday, February 07 | 2:30PM - 4:30PM
Panel: The Integrative Human Microbiome Project (iHMP)
Room: Grays/Longs Peak
The Integrative Human Microbiome Project (iHMP) is the second phase of the National Institute of Health (NIH) Common Fund's Human Microbiome Project (HMP) program. The mission of the overall HMP is to generate resources to permit comprehensive characterization of the human microbiota to further our understanding of how the microbiome impacts human health and disease. In this phase of the program, the iHMP is creating integrated longitudinal datasets of biological properties from both the microbiome and host from three different cohort studies of microbiome-associated conditions using multiple 'omics' technologies. Tools, datasets and other resources from the first phase of the project are available at the HMP DACC. The three iHMP projects have recently completed primary data generation and are entering an initial analysis phase, and this session will detail the data and resources made available to the research community by: 1) the Multi-Omic Microbiome Study: Pregnancy Initiative (MOMS-PI) at Virginia Commonwealth University, 2) the Inflammatory Bowel Disease Multi'omic Data (IBDMDB) resource from the Broad Institute and a nation-wide research tam, and 3) Integrated Personal 'Omics Profiling (IPOP) from Stanford University and the Jackson Laboratory for Genomic Medicine. For more information or to get involved with the iHMP, please see http://hmp2.org.
Speaker 3 of 4
George M. Weinstock, The Jackson Laboratory, USA

Tuesday, February 07 | 2:30PM - 4:30PM
Panel: The Integrative Human Microbiome Project (iHMP)
Room: Grays/Longs Peak
The Integrative Human Microbiome Project (iHMP) is the second phase of the National Institute of Health (NIH) Common Fund's Human Microbiome Project (HMP) program. The mission of the overall HMP is to generate resources to permit comprehensive characterization of the human microbiota to further our understanding of how the microbiome impacts human health and disease. In this phase of the program, the iHMP is creating integrated longitudinal datasets of biological properties from both the microbiome and host from three different cohort studies of microbiome-associated conditions using multiple 'omics' technologies. Tools, datasets and other resources from the first phase of the project are available at the HMP DACC. The three iHMP projects have recently completed primary data generation and are entering an initial analysis phase, and this session will detail the data and resources made available to the research community by: 1) the Multi-Omic Microbiome Study: Pregnancy Initiative (MOMS-PI) at Virginia Commonwealth University, 2) the Inflammatory Bowel Disease Multi'omic Data (IBDMDB) resource from the Broad Institute and a nation-wide research tam, and 3) Integrated Personal 'Omics Profiling (IPOP) from Stanford University and the Jackson Laboratory for Genomic Medicine. For more information or to get involved with the iHMP, please see http://hmp2.org.
Speaker 4 of 4
Anup Mahurkar, University of Maryland Baltimore, USA

Tuesday, February 07 | 2:30PM - 4:30PM
Workshop 2: Inflammation and Immunity Crosstalk
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 1 of 9
* Giorgio Trinchieri, NCI, National Institutes of Health, USA


Tuesday, February 07 | 2:30PM - 4:30PM
Workshop 2: Inflammation and Immunity Crosstalk
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 2 of 9
* Laurence Zitvogel, Institut Gustave Roussy, France


Tuesday, February 07 | 2:30PM - 4:30PM
Workshop 2: Inflammation and Immunity Crosstalk
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 3 of 9
Giuseppe Di Caro, University of California, San Diego, USA
Immunoglobulin A Attenuates Colonic Tumorigenesis by Controlling Microbial Translocation and Tumor-Elicited Inflammation


Tuesday, February 07 | 2:30PM - 4:30PM
Workshop 2: Inflammation and Immunity Crosstalk
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 4 of 9
Ankit Malik, University of Chicago, USA
IL-33 Regulates the IgA-Microbiota Axis to Restrain IL-1alpha Dependent Colitis and Tumorigenesis


Tuesday, February 07 | 2:30PM - 4:30PM
Workshop 2: Inflammation and Immunity Crosstalk
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 5 of 9
Andrea Ponzetta, Humanitas Clinical and Research Center, Italy
Neutrophils are Protective in Cancerogenesis by Altering Tumor Microenvironment and Controlling Intestinal Microbiota


Tuesday, February 07 | 2:30PM - 4:30PM
Workshop 2: Inflammation and Immunity Crosstalk
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 6 of 9
Sabine Waeber, Université de Lausanne, Switzerland
Mesenchymal Stem Cells from Human Squamous Cell Lung Carcinoma Modulate Natural Killer (NK) Cell Phenotype and Function


Tuesday, February 07 | 2:30PM - 4:30PM
Workshop 2: Inflammation and Immunity Crosstalk
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 7 of 9
Martina Molgora, Humanitas Research Hospital, Italy
Interleukin-1 Receptor 8 (IL-1R8) Plays a Crucial Role in Natural Killer Cell Differentiation and Function


Tuesday, February 07 | 2:30PM - 4:30PM
Workshop 2: Inflammation and Immunity Crosstalk
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 8 of 9
Venuprasad K. Poojary, Baylor Institute for Immunology Research, USA
A Novel Role for Itch in Inhibition of IL-17-Mediated Colon Inflammation and Tumorigenesis by ROR-gammat Ubiquitination


Tuesday, February 07 | 2:30PM - 4:30PM
Workshop 2: Inflammation and Immunity Crosstalk
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 9 of 9
Christoph Andreas Reichel, Walter Brendel Centre of Experimental Medicine, Germany
Complex Formation of uPA and PAI-1 Promotes Myeloid Leukocyte Trafficking


Tuesday, February 07 | 4:30PM - 5:00PM
Coffee Available
Room: Longs Peak Foyer


Tuesday, February 07 | 5:00PM - 7:00PM
Human Microbiome Studies
Room: Grays/Longs Peak

Speaker 1 of 5
* Robert E.W. Hancock, University of British Columbia, Canada

Tuesday, February 07 | 5:00PM - 7:00PM
Human Microbiome Studies
Room: Grays/Longs Peak

Speaker 2 of 5
Andrew L. Goodman, Yale School of Medicine, USA
Cooperation and Competition in the Human Gut Microbiome

Tuesday, February 07 | 5:00PM - 7:00PM
Human Microbiome Studies
Room: Grays/Longs Peak

Speaker 3 of 5
Julie A. Segre, National Institutes of Health, USA
Human Skin Microbiome: Topographic Functional Mapping of Healthy Volunteers and Patient Populations

Tuesday, February 07 | 5:00PM - 7:00PM
Human Microbiome Studies
Room: Grays/Longs Peak

Speaker 4 of 5
Gary D. Wu, University of Pennsylvania, USA
Diet, the Gut Microbiome and Inflammatory Bowel Disease

Tuesday, February 07 | 5:00PM - 7:00PM
Human Microbiome Studies
Room: Grays/Longs Peak

Speaker 5 of 5
Renuka Nayak, University of California, San Francisco, USA
Short Talk: Methotrexate Is an Antibacterial Drug Metabolized by Human Gut Bacteria

Tuesday, February 07 | 5:00PM - 7:00PM
Tumor-Elicited Inflammation
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 1 of 5
* Ming O. Li, Memorial Sloan Kettering Cancer Center, USA


Tuesday, February 07 | 5:00PM - 7:00PM
Tumor-Elicited Inflammation
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 2 of 5
Yinling Hu, NCI, National Institutes of Health, USA
IKKalpha, Autoimmunity and Chronic Fungal Infection in Esophageal and Skin Carcinogenesis


Tuesday, February 07 | 5:00PM - 7:00PM
Tumor-Elicited Inflammation
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 3 of 5
Hua E. Yu, Beckman Research Institute, City of Hope, USA
Stat 3 in Cancer Inflammation and as a Target in Cancer


Tuesday, February 07 | 5:00PM - 7:00PM
Tumor-Elicited Inflammation
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 4 of 5
Owen J. Sansom, Beatson Institute of Cancer Research, UK
Targeting Myeloid Cells in Epithelial Cancers


Tuesday, February 07 | 5:00PM - 7:00PM
Tumor-Elicited Inflammation
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 5 of 5
Elena Tosti, Albert Einstein College of Medicine, USA
Short Talk: MMR and Tgfb Signaling Cooperate in Suppressing Inflammation-Associated Colorectal Tumorigenesis


Tuesday, February 07 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Colorado Rockies Ballroom
No registration fees are used to fund alcohol served at this function.

Tuesday, February 07 | 7:30PM - 10:00PM
Poster Session 2
Room: Colorado Rockies Ballroom


Wednesday, February 08 | 7:00AM - 8:00AM
Breakfast
Room: Colorado Rockies Ballroom


Wednesday, February 08 | 8:00AM - 11:00AM
Genetic Diversity and Communication
Room: Grays/Longs Peak

Speaker 1 of 7
* Thaddeus S. Stappenbeck, Cleveland Clinic, USA

Wednesday, February 08 | 8:00AM - 11:00AM
Genetic Diversity and Communication
Room: Grays/Longs Peak

Speaker 2 of 7
Karen Guillemin, University of Oregon, USA
Modulation of Host Innate Immune Responses by Individual Microbiota Members

Wednesday, February 08 | 8:00AM - 11:00AM
Genetic Diversity and Communication
Room: Grays/Longs Peak

Speaker 3 of 7
Eran Segal, Weizmann Institute of Science, Israel
Personalized Nutrition using Gut Microbiome and Clinical Data

Wednesday, February 08 | 8:00AM - 11:00AM
Genetic Diversity and Communication
Room: Grays/Longs Peak


Coffee Break

Wednesday, February 08 | 8:00AM - 11:00AM
Genetic Diversity and Communication
Room: Grays/Longs Peak

Speaker 5 of 7
Robert E.W. Hancock, University of British Columbia, Canada
Network Biology Approaches to Understanding Inflammation

Wednesday, February 08 | 8:00AM - 11:00AM
Genetic Diversity and Communication
Room: Grays/Longs Peak

Speaker 6 of 7
James M. Musser, Methodist Hospital Research Institute, USA
Integrative Approach to Investigating Human Pathogen-Host Interactions: A Nightmare of Genomic Diversity?

Wednesday, February 08 | 8:00AM - 11:00AM
Genetic Diversity and Communication
Room: Grays/Longs Peak

Speaker 7 of 7
Mahesh S. Desai, Luxembourg Institute of Health, Luxembourg
Short Talk: A Dietary Fiber-Deprived Gut Microbiota Degrades the Colonic Mucus Barrier and Enhances Pathogen Susceptibility

Wednesday, February 08 | 8:00AM - 11:15AM
Inflammation and Immunity Crosstalk I
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 1 of 8
* Shannon J. Turley, Genentech, Inc., USA


Wednesday, February 08 | 8:00AM - 11:15AM
Inflammation and Immunity Crosstalk I
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 2 of 8
Michael Karin, University of California, San Diego, USA
Immune Crosstalk in Tumors


Wednesday, February 08 | 8:00AM - 11:15AM
Inflammation and Immunity Crosstalk I
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 3 of 8
Alberto Mantovani, Humanitas University, Italy
Innate Immune Pathways and the Tumor Microenvironment


Wednesday, February 08 | 8:00AM - 11:15AM
Inflammation and Immunity Crosstalk I
This session is from Inflammation-Driven Cancer
Room: Quandary Peak


Coffee Break


Wednesday, February 08 | 8:00AM - 11:15AM
Inflammation and Immunity Crosstalk I
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 5 of 8
Ming O. Li, Memorial Sloan Kettering Cancer Center, USA
Immunity and Tolerance in Cancer


Wednesday, February 08 | 8:00AM - 11:15AM
Inflammation and Immunity Crosstalk I
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 6 of 8
Toby Lawrence, INSERM, France
Mechanisms of Tumour-Associated Macrophage (TAM) Polarisation


Wednesday, February 08 | 8:00AM - 11:15AM
Inflammation and Immunity Crosstalk I
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 7 of 8
Sven Brandau, University Hospital Essen, Germany
Short Talk: Absence of Endogenous Toll-Like Receptor Sensing Unleashes Protective Anti-Tumor Immunity and Tumor Regression


Wednesday, February 08 | 8:00AM - 11:15AM
Inflammation and Immunity Crosstalk I
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 8 of 8
George Plitas, Memorial Sloan Kettering Cancer Center, USA
Short Talk: CD177 Identifies a Novel Subset of Regulatory T Cells (Treg) Infiltrating Human Breast Cancer


Wednesday, February 08 | 11:00AM - 5:00PM
On Own for Lunch


Wednesday, February 08 | 11:00AM - 1:00PM
Poster Setup
Room: Colorado Rockies Ballroom


Wednesday, February 08 | 1:00PM - 10:00PM
Poster Viewing
Room: Colorado Rockies Ballroom


Wednesday, February 08 | 4:30PM - 5:00PM
Coffee Available
Room: Longs Peak Foyer


Wednesday, February 08 | 5:00PM - 7:00PM
Microbiome and Disease
Room: Grays/Longs Peak

Speaker 1 of 5
* Timothy K. Lu, Massachusetts Institute of Technology, USA

Wednesday, February 08 | 5:00PM - 7:00PM
Microbiome and Disease
Room: Grays/Longs Peak

Speaker 2 of 5
Thaddeus S. Stappenbeck, Cleveland Clinic, USA
Microbial Metabolites that Modify Intestinal Wound Repair

Wednesday, February 08 | 5:00PM - 7:00PM
Microbiome and Disease
Room: Grays/Longs Peak

Speaker 3 of 5
Kathryn E. Holt, University of Melbourne, Australia
Klebsiella Pneumoniae and the Microbiome

Wednesday, February 08 | 5:00PM - 7:00PM
Microbiome and Disease
Room: Grays/Longs Peak

Speaker 4 of 5
Ami S. Bhatt, Stanford University, USA
Metagenomics and the Microbiome in Stem Cell Transplantation

Wednesday, February 08 | 5:00PM - 7:00PM
Microbiome and Disease
Room: Grays/Longs Peak

Speaker 5 of 5
Lindsay R. Kalan, University of Wisconsin Madison, USA
Short Talk: Multi-Kingdom Microbial Communities of Chronic Non-Healing Wounds and their Association with Clinical Outcomes

Wednesday, February 08 | 5:00PM - 7:00PM
Stromal Cells and the Tumor Microenvironment
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 1 of 4
* Alberto Mantovani, Humanitas University, Italy


Wednesday, February 08 | 5:00PM - 7:00PM
Stromal Cells and the Tumor Microenvironment
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 2 of 4
Shannon J. Turley, Genentech, Inc., USA
Leukocyte Function and Positioning in Diverse Stromal Niches


Wednesday, February 08 | 5:00PM - 7:00PM
Stromal Cells and the Tumor Microenvironment
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 3 of 4
Daniel L. Worthley, SAHMRI, Adelaide, Australia
Intestinal Mesenchyme in the Normal and Neoplastic Colon


Wednesday, February 08 | 5:00PM - 7:00PM
Stromal Cells and the Tumor Microenvironment
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 4 of 4
Raghu Kalluri, University of Texas MD Anderson Cancer Center, USA
The Functional Role of Inflammation and Fibrosis in Pancreatic Cancer


Wednesday, February 08 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Colorado Rockies Ballroom
No registration fees are used to fund alcohol served at this function.

Wednesday, February 08 | 7:30PM - 10:00PM
Poster Session 3
Room: Colorado Rockies Ballroom


Thursday, February 09 | 7:00AM - 8:00AM
Breakfast
Room: Colorado Rockies Ballroom


Thursday, February 09 | 8:00AM - 11:00AM
Molecular Discovery of Novel Antimicrobials
Room: Grays/Longs Peak

Speaker 1 of 7
* Sean F. Brady, Rockefeller University, USA

Thursday, February 09 | 8:00AM - 11:00AM
Molecular Discovery of Novel Antimicrobials
Room: Grays/Longs Peak

Speaker 2 of 7
Andreas Peschel, University of Tübingen, Germany
Staphylococcus Aureus in the Human Nose – A Facultative Pathogen's Interference with Microbiota

Thursday, February 09 | 8:00AM - 11:00AM
Molecular Discovery of Novel Antimicrobials
Room: Grays/Longs Peak

Speaker 3 of 7
William Michael Dunne, bioMérieux, Inc., USA
Next-Generation Antimicrobial Susceptibility Testing

Thursday, February 09 | 8:00AM - 11:00AM
Molecular Discovery of Novel Antimicrobials
Room: Grays/Longs Peak


Coffee Break

Thursday, February 09 | 8:00AM - 11:00AM
Molecular Discovery of Novel Antimicrobials
Room: Grays/Longs Peak

Speaker 5 of 7
Eric J. Alm, Massachusetts Institute of Technology, USA
FMT Complex Analyses

Thursday, February 09 | 8:00AM - 11:00AM
Molecular Discovery of Novel Antimicrobials
Room: Grays/Longs Peak

Speaker 6 of 7
Silvio M. Vieira, Yale University, USA
Short Talk: A Gut Commensal Breaches Both Gut Lymphatic and Vascular Barriers to Drive Systemic Autoimmunity

Thursday, February 09 | 8:00AM - 11:00AM
Molecular Discovery of Novel Antimicrobials
Room: Grays/Longs Peak

Speaker 7 of 7
Jonathan L. Linehan, NIAID, National Institutes of Health, USA
Short Talk: Cutaneous Commensal Bacteria Drive an Unconventional T Cell Response that Accelerates Wound Healing

Thursday, February 09 | 8:00AM - 11:00AM
Inflammation and Immunity Crosstalk II
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 1 of 7
* Jane L. Grogan, Arsenal Biosciences, USA


Thursday, February 09 | 8:00AM - 11:00AM
Inflammation and Immunity Crosstalk II
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 2 of 7
Weiping Zou, University of Michigan, USA
Metabolic Control of Effector T Cells and Regulatory T Cells in Tumor


Thursday, February 09 | 8:00AM - 11:00AM
Inflammation and Immunity Crosstalk II
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 3 of 7
Thomas Gajewski, University of Chicago, USA
Host Factors Controlling Anti-Tumor Immunity: Unexpected Impact of the Commensal Microbiota


Thursday, February 09 | 8:00AM - 11:00AM
Inflammation and Immunity Crosstalk II
This session is from Inflammation-Driven Cancer
Room: Quandary Peak


Coffee Break


Thursday, February 09 | 8:00AM - 11:00AM
Inflammation and Immunity Crosstalk II
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 5 of 7
E. John Wherry, University of Pennsylvania, USA
Molecular Basis of T Cell Exhaustion: Insights for Immunotherapy


Thursday, February 09 | 8:00AM - 11:00AM
Inflammation and Immunity Crosstalk II
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 6 of 7
Martin Oft, ARMO BioSciences, USA
PEGylated IL-10 Induces Th1 and Th2 Immunity, Proliferation of PD1+ Lag-3+ CD8+ T Cells and Multiclonal T Cell Expansion in Cancer Patients


Thursday, February 09 | 8:00AM - 11:00AM
Inflammation and Immunity Crosstalk II
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 7 of 7
Bronislaw Pytowski, Eli Lilly, USA
Short Talk: The Effect of VEGFR2 Inhibition on Tumor Blood Vessels and Immune Landscape


Thursday, February 09 | 11:00AM - 5:00PM
On Own for Lunch


Thursday, February 09 | 2:30PM - 4:30PM
Workshop 2: Metagenomic Analysis
Room: Grays/Longs Peak

Speaker 1 of 7
* Eric J. Alm, Massachusetts Institute of Technology, USA

Thursday, February 09 | 2:30PM - 4:30PM
Workshop 2: Metagenomic Analysis
Room: Grays/Longs Peak

Speaker 2 of 7
Michael G. Constantinides, NIAID, National Institutes of Health, USA
Mucosal-Associated Invariant T Cells Respond to Cutaneous Microbiota

Thursday, February 09 | 2:30PM - 4:30PM
Workshop 2: Metagenomic Analysis
Room: Grays/Longs Peak

Speaker 3 of 7
Collin Edington, Massachusetts Institute of Technology, USA
Development of Bioreactor Devices for Microbiome and Multi-Organ Interaction Studies

Thursday, February 09 | 2:30PM - 4:30PM
Workshop 2: Metagenomic Analysis
Room: Grays/Longs Peak

Speaker 4 of 7
Sho Kitamoto, University of MIchigan Medical School, USA
Gut Inflammation-Driven Metabolic Reprograming Regulates the Competitive Fitness of Pathogenic E. coli

Thursday, February 09 | 2:30PM - 4:30PM
Workshop 2: Metagenomic Analysis
Room: Grays/Longs Peak

Speaker 5 of 7
David T. Riglar, Harvard Medical School, USA
Gut Feelings: Engineering Synthetic Bacterial Circuits to Functionally Probe the Mammalian Gut Microbiome

Thursday, February 09 | 2:30PM - 4:30PM
Workshop 2: Metagenomic Analysis
Room: Grays/Longs Peak

Speaker 6 of 7
Neil Surana, Boston Children’s Hospital, USA
Discovery of Disease-Modulating Microbiota Using Microbial Pedigree Analysis

Thursday, February 09 | 2:30PM - 4:30PM
Workshop 2: Metagenomic Analysis
Room: Grays/Longs Peak

Speaker 7 of 7
Ana Weil, Massachusetts General Hospital, USA
The Human Gut Microbiota Predicts Susceptibility to Vibrio cholerae O1 Infection

Thursday, February 09 | 2:30PM - 4:30PM
Workshop 3: Prevention and Therapy
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 1 of 8
* Carola H. Ries, Roche Innovation Center Munich, Germany


Thursday, February 09 | 2:30PM - 4:30PM
Workshop 3: Prevention and Therapy
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 2 of 8
* E. John Wherry, University of Pennsylvania, USA


Thursday, February 09 | 2:30PM - 4:30PM
Workshop 3: Prevention and Therapy
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 3 of 8
Eduardo Bonavita, Cancer Research UK Manchester Institute, University of Manchester, UK
COX-2 Expression Positively Associates with Tumor-Promoting Inflammatory Factors and Negatively with Anti-Tumor Immune Pathways in Human Cancer


Thursday, February 09 | 2:30PM - 4:30PM
Workshop 3: Prevention and Therapy
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 4 of 8
David N. Brindley, University of Alberta, Canada
Blocking the Inflammatory Effects of Lysophosphatidate Signaling as a New Strategy for Decreasing Tumor Growth, Metastasis and Improving Chemotherapy


Thursday, February 09 | 2:30PM - 4:30PM
Workshop 3: Prevention and Therapy
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 5 of 8
Feng Zhu, NCI, National Institutes of Health, USA
Fungal Infection and Immune Dysfunction Contribute to Esophageal Carcinogenesis


Thursday, February 09 | 2:30PM - 4:30PM
Workshop 3: Prevention and Therapy
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 6 of 8
Kayla Knilans, National Institutes of Health, USA
Type 2 Signaling Improves Survival and Reduces Tumor Growth in a Mouse Model of Colitis-Associated Cancer


Thursday, February 09 | 2:30PM - 4:30PM
Workshop 3: Prevention and Therapy
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 7 of 8
Jeff Kwak, University of Colorado Denver, USA
Complement Activation Mediates Lung Cancer Progression and Metastasis through Alterations in CD4 T Lymphocytes


Thursday, February 09 | 2:30PM - 4:30PM
Workshop 3: Prevention and Therapy
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 8 of 8
Max D. Wellenstein, Netherlands Cancer Institute, Netherlands
Loss of p53 Drives Systemic Neutrophilic Inflammation in Breast Cancer


Thursday, February 09 | 4:30PM - 5:00PM
Coffee Available
Room: Longs Peak Foyer


Thursday, February 09 | 5:00PM - 7:00PM
Systems Microbiology
Room: Grays/Longs Peak

Speaker 1 of 5
* Karen Guillemin, University of Oregon, USA

Thursday, February 09 | 5:00PM - 7:00PM
Systems Microbiology
Room: Grays/Longs Peak

Speaker 2 of 5
Timothy K. Lu, Massachusetts Institute of Technology, USA
Engineering the Microbiome

Thursday, February 09 | 5:00PM - 7:00PM
Systems Microbiology
Room: Grays/Longs Peak

Speaker 3 of 5
James Amos-Landgraf, University of Missouri, USA
Suppression of Tumor Growth using Biofilm Producing Sulfate-reducing Bacteria in a Rat Model of Colon Cancer

Thursday, February 09 | 5:00PM - 7:00PM
Systems Microbiology
Room: Grays/Longs Peak

Speaker 4 of 5
Sean F. Brady, Rockefeller University, USA
Microbial Biosynthetic Diversity

Thursday, February 09 | 5:00PM - 7:00PM
Systems Microbiology
Room: Grays/Longs Peak

Speaker 5 of 5
Alexandra Zhernakova, University Medical Center Groningen, Netherlands
Short Talk: Interaction of Genetics and Food Intake Influences Gut Microbiota Composition

Thursday, February 09 | 5:00PM - 6:45PM
Prevention and Therapy
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 1 of 5
* Fiona M. Powrie, University of Oxford, UK


Thursday, February 09 | 5:00PM - 6:45PM
Prevention and Therapy
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 2 of 5
Carola H. Ries, Roche Innovation Center Munich, Germany
Combining Macrophage Targeting with Cancer Immunotherapies


Thursday, February 09 | 5:00PM - 6:45PM
Prevention and Therapy
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 3 of 5
Jane L. Grogan, Arsenal Biosciences, USA
The Inhibitory Immunoreceptor TIGIT Limits Anti-Tumor Immunity


Thursday, February 09 | 5:00PM - 6:45PM
Prevention and Therapy
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 4 of 5
Jen Morton, Cancer Research UK Beatson Institute, Scotland
Short Talk: Myeloid Cells as a Therapeutic Target in Pancreatic Cancer


Thursday, February 09 | 5:00PM - 6:45PM
Prevention and Therapy
This session is from Inflammation-Driven Cancer
Room: Quandary Peak

Speaker 5 of 5
Kristen M. Larsen, University of South Carolina, USA
Short Talk: The Role of Interleukin 33/ST2 Axis in Liver Metastasis of Colorectal Cancer


Thursday, February 09 | 6:45PM - 7:00PM
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
This session is from Inflammation-Driven Cancer
Room: Quandary Peak


Thursday, February 09 | 7:00PM - 7:15PM
Meeting Wrap-Up: Outcomes and Future Directions
Room: Grays/Longs Peak

Speaker 1 of 1
* William Michael Dunne, bioMérieux, Inc., USA

Thursday, February 09 | 7:15PM - 8:15PM
Social Hour with Lite Bites
Room: Colorado Rockies Ballroom
No registration fees are used to fund alcohol served at this function.

Thursday, February 09 | 8:15PM - 11:00PM
Entertainment
Room: Colorado Rockies Ballroom
Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.

Thursday, February 09 | 8:15PM - 11:00PM
Cash Bar
Room: Colorado Rockies Ballroom


Friday, February 10 | 10:24AM - 10:24AM
Departure


*Session Chair
†Invited, not yet responded.